Elite Pharmaceuticals, Inc. Current State and Local Tax Expense (Benefit)
Elite Pharmaceuticals, Inc. (ELTP) reported Current State and Local Tax Expense (Benefit) of $1.40 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2026-06-29
- Elite Pharmaceuticals, Inc. current state and local tax expense (benefit) for fiscal 2026 was $1.40M, a 198.93% increase from fiscal 2025.
- Elite Pharmaceuticals, Inc. current state and local tax expense (benefit) for fiscal 2025 was $468.00K, a 36.44% increase from fiscal 2024.
- Elite Pharmaceuticals, Inc. current state and local tax expense (benefit) for fiscal 2024 was $343.00K, a 19.10% decline from fiscal 2023.
- Elite Pharmaceuticals, Inc. current state and local tax expense (benefit) for fiscal 2023 was $424.00K, a 2.61% decline from fiscal 2022.
| Period end | Current State and Local Tax Expense (Benefit) 12 month | Current State and Local Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2026-03-31 | $1.40M 10-K · filed 2026-06-29 | |
| 2025-03-31 | $468.00K 10-K · filed 2026-06-29 | |
| 2024-03-31 | $343.00K 10-K · filed 2025-06-30 | |
| 2023-03-31 | $424.00K 10-K · filed 2024-07-01 | $424.03K 10-K · filed 2023-06-29 |
| 2022-03-31 | $435.38K 10-K · filed 2023-06-29 | -$435.38K 10-K · filed 2022-06-29 |
| 2019-03-31 | $3.00K 10-K · filed 2020-06-29 | |
| 2018-03-31 | -$5.50K 10-K · filed 2019-06-21 | |
| 2017-03-31 | -$2.50K 10-K · filed 2018-06-14 | |
| 2016-03-31 | -$4.05K 10-K · filed 2018-06-14 | -$4.05M 10-K · filed 2016-06-15 |
| 2015-03-31 | $3.25K 10-K · filed 2017-06-14 | -$3.25K 10-K · filed 2015-06-15 |
| 2014-03-31 | -$3.10M 10-K · filed 2016-06-15 | $3.10K 10-K · filed 2014-06-30 |
| 2013-03-31 | $6.10K 10-K · filed 2014-06-30 | -$6.10K 10-K · filed 2013-06-21 |
| 2012-03-31 | -$2.85K 10-K · filed 2013-06-21 |